期刊文献+

炎症性肠病中的自噬异常与中药干预研究进展 被引量:3

Abnormal regulation of autophagy in inflammatory bowel disease and the intervention of traditional Chinese medicine
下载PDF
导出
摘要 自噬(autophagy)是由溶酶体介导的细胞程序性降解途径,对维持细胞的稳态,清除胞内毒性物质和代谢能量的平衡具有重要的意义。研究表明自噬异常是炎症性肠病(inflammatory bowel disease,IBD)发生、发展的重要机制,与炎症反应的失调、病原菌侵袭和肠道黏膜的修复障碍密切相关。深入认识自噬调节在IBD防治中的价值对于优化现有治疗策略具有重要意义。本文基于中药在IBD防治中的应用现状,从自噬调节的角度分析了相关中药及其活性成分的作用机制和应用前景,并对相关研究存在的问题和发展趋势进行了初步探讨。 Autophagy is a lysosome-mediated cell-programmed degradation pathway that plays an important role in maintaining cell homeostasis, eliminating intracellular toxic substances and the balance of metabolic energy. Research shows that autophagy is closely related to the dysregulation of inflammatory immune response, pathogen invasion and the repair of intestinal mucosa, and is an important mechanism of inflammatory bowel disease (IBD). These findings are important for understanding the mechanisms of IBD and optimizing existing treatment strategies. In this review, the commonly used traditional Chinese medicines for IBD treatment were summarized from the perspective of autophagy regulation. The implications of autophagy regulation on the mechanism of research related Chinese medicine ingredients and the problems and development trends of related research were discussed.
作者 范淇淋 郑啸 王淑美 郝海平 李萍 FAN Qilin;ZHENG Xiao;WANG Shumei;HAO Haiping;LI Ping(School of Traditional Chinese Medicine, Guangdong Pharmaceutical University Guangzhou 510000, Guangdong, China;State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210000, Jiangsu, China)
出处 《中国临床药理学与治疗学》 CAS CSCD 2019年第4期471-480,共10页 Chinese Journal of Clinical Pharmacology and Therapeutics
基金 国家自然科学基金项目(81720108032 81421005)
关键词 自噬 中药 炎症性肠病 临床治疗 autophagy traditional Chinese medicine inflammatory bowel disease clinical treatment
  • 相关文献

参考文献6

二级参考文献71

  • 1王新月.溃疡性结肠炎分期辨治体会[J].江苏中医药,2006,27(1):10-11. 被引量:23
  • 2戴彦成,唐志鹏,李凯,王臻楠.溃疡性结肠炎中肠道动力学研究进展[J].世界华人消化杂志,2007,15(7):721-724. 被引量:14
  • 3[1]Comillie F,Shealy D,D'Haens G,et al.Infliximab induces potent anti-inflammatory and local immunomodulatory activity but no systemic immune suppression in patients with Crohn's disease.Aliment Pharmacol Ther,2001,15(4):463~73.
  • 4[2]Kono T,Nomura M,Kasai S,et al.Effect of ecabet sodium enema on mildly no moderately active ulcerative proctosigrnoiditis: an open-label study.Am J Gastroenterol,2001,96(3):793~7.
  • 5[3]Bennink R,Peeters M,D'Haens G,et al.Tc-99m HMPAO white blood call scintigraphy in the assessment of the extent and se verity of an acute exacerbation of ulcerative colitis.Clin Nucl Med,2001,26(2):99~104.
  • 6[4]Bitton A,Peppercorn MA,Antonioli DA,et al.Clinical,biological,and histologic parameters as predictors of relapse in ulcerative colitis.Gastroenterology,2001,120( 1 ): 13~ 20.
  • 7[5]Ierardi E,Principi M,Francavilla R,et al.Oral tacrolimus longterm therapy in patients with Crohn's disease and steroid resistance.Aliment Pharmacol Ther,2001,15(3):371~7.
  • 8[6]Cortot A,Colombel JF,Rutgeerts P,et al.Switch from systemic steroids to budesonide in steroid dependent patients with inactive Crohn's disease.Gut,201,48(2): 186~90.
  • 9[7]Ettorre GM,Peseatofi M,Panis Y,et al.Mucosal changes in ileal pouches after restorative proctocolectomy for ulcerative and Crohn's colitis.Dis Colon Rectum,2000,43(12): 1743 ~8.
  • 10[8]Rieber A,Aschoff A,Nussle K,et al.MRI in the diagnosis of small bowel disease: use of positive and negative oral contrast media in combination with enteroclysis.Eur Radiol,2000,10(9): 1377~82.

共引文献136

同被引文献38

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部